Total Payments
$18,053
2024 Payments
$2,877
Companies
51
Transactions
1,318
Medicare Patients
11,553
Medicare Billing
$392,549
Payment Breakdown by Category
Food & Beverage$17,949 (99.4%)
Education$103.71 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,949 | 1,310 | 99.4% |
| Education | $103.71 | 8 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,743 | 347 | $0 (2024) |
| ABBVIE INC. | $1,818 | 136 | $0 (2024) |
| Lilly USA, LLC | $1,592 | 111 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,467 | 159 | $0 (2024) |
| PFIZER INC. | $1,177 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,151 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $734.05 | 55 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $566.29 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $504.97 | 34 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $417.77 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,877 | 194 | Novo Nordisk Inc ($584.98) |
| 2023 | $2,317 | 159 | Novo Nordisk Inc ($668.04) |
| 2022 | $2,511 | 180 | Novo Nordisk Inc ($586.21) |
| 2021 | $2,827 | 194 | Novo Nordisk Inc ($939.12) |
| 2020 | $1,541 | 101 | Novo Nordisk Inc ($368.45) |
| 2019 | $1,601 | 128 | Novo Nordisk Inc ($327.18) |
| 2018 | $1,934 | 158 | Novo Nordisk Inc ($532.48) |
| 2017 | $2,444 | 204 | Novo Nordisk Inc ($736.88) |
All Payment Transactions
1,318 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: PAIN | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Obesity | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 55 | 2,791 | 4,177 | $185,908 | $85,205 |
| 2022 | 49 | 2,640 | 3,614 | $183,975 | $89,401 |
| 2021 | 45 | 3,751 | 4,330 | $213,157 | $132,979 |
| 2020 | 51 | 2,371 | 3,042 | $183,140 | $84,964 |
Total Patients
11,553
Total Services
15,163
Medicare Billing
$392,549
Procedure Codes
200
All Medicare Procedures & Services
200 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 171 | $26,334 | $13,690 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 81 | 81 | $14,260 | $9,664 | 67.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 52 | $11,256 | $6,067 | 53.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 162 | 262 | $11,004 | $4,264 | 38.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $5,780 | $3,452 | 59.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 167 | 254 | $11,430 | $3,299 | 28.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,165 | $3,089 | 97.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 173 | 357 | $3,570 | $3,000 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 160 | 291 | $11,640 | $2,999 | 25.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $4,420 | $2,547 | 57.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 41 | $4,100 | $2,315 | 56.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 164 | 285 | $5,985 | $2,160 | 36.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $2,262 | $2,124 | 93.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 92 | 128 | $5,790 | $1,740 | 30.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 123 | 170 | $3,570 | $1,602 | 44.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 50 | 56 | $2,800 | $1,580 | 56.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 27 | 39 | $2,340 | $1,469 | 62.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 16 | $2,400 | $1,429 | 59.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $7,800 | $1,339 | 17.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $2,520 | $1,287 | 51.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 74 | 94 | $2,820 | $1,209 | 42.9% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 73 | 95 | $2,850 | $1,145 | 40.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,440 | $1,140 | 79.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 129 | 186 | $2,232 | $1,044 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 111 | $3,996 | $1,012 | 25.3% |
About Dr. Coby Harrison, M.D
Dr. Coby Harrison, M.D is a Internal Medicine healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1891054359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Coby Harrison, M.D has received a total of $18,053 in payments from pharmaceutical and medical device companies, with $2,877 received in 2024. These payments were reported across 1,318 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($17,949).
As a Medicare-enrolled provider, Harrison has provided services to 11,553 Medicare beneficiaries, totaling 15,163 services with total Medicare billing of $392,549. Data is available for 4 years (2020–2023), covering 200 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mobile, AL
- Active Since 05/03/2012
- Last Updated 01/28/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891054359
Products in Payments
- Ozempic (Drug) $1,396
- XARELTO (Drug) $1,137
- FARXIGA (Drug) $904.44
- Wegovy (Drug) $870.53
- Saxenda (Drug) $794.66
- VRAYLAR (Drug) $752.68
- UBRELVY (Drug) $621.70
- Victoza (Drug) $601.80
- NURTEC ODT (Drug) $584.45
- TRELEGY ELLIPTA (Drug) $508.10
- XIFAXAN (Drug) $503.00
- TRULICITY (Drug) $502.05
- Rybelsus (Drug) $453.94
- ENTRESTO (Drug) $434.70
- MOUNJARO (Drug) $425.36
- QULIPTA (Drug) $336.22
- Kerendia (Drug) $293.99
- EMGALITY (Drug) $241.70
- BASAGLAR (Drug) $230.35
- REXULTI (Drug) $188.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mobile
Phillip Henderson, D.o, D.O
Internal Medicine — Payments: $581,808
Internal Medicine $581,808
Thomas Mckelvey, Md, MD
Internal Medicine — Payments: $525,947
Internal Medicine $525,947
Dr. Mary Honkanen, Md, MD
Internal Medicine — Payments: $479,092
Internal Medicine $479,092
Bobby Wrights, Md, MD
Internal Medicine — Payments: $126,247
Internal Medicine $126,247
Dr. Rahel Aziz, Md, MD
Internal Medicine — Payments: $39,226
Internal Medicine $39,226
Dr. Wilburn Bolton, M.d, M.D
Internal Medicine — Payments: $36,214
Internal Medicine $36,214